Ellenbarrie Industrial Gases Ltd
NSE: ELLEN BSE: 544421Energy
Ellenbarrie Industrial Gases Ltd. is engaged in the business of oxygen and nitrogen. The Company is a manufacturer and supplier of industrial gases in the eastern and southern India, both in bulk and packaged form. It is engaged in the medical, chemical, construction, defense and energy businesses.
₹272
52W: ₹175 — ₹638
PE 38.4 · Book ₹65.4 · +316% vs bookMarket Cap₹3,830 Cr
Stock P/E38.4Price to Earnings
ROCE18.2%Return on Capital
ROE17.8%Return on Equity
Div. Yield0%Face Value ₹2
Strengths
- +Company has reduced debt.
Weaknesses
- −Stock is trading at 4.17 times its book value
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company has a low return on equity of 12.2% over last 3 years.
- −Earnings include an other income of Rs.46.9 Cr.
- −Debtor days have increased from 76.0 to 96.5 days.
Shareholding Pattern
Promoters77.15%
FIIs1.31%
DIIs13.02%
Public8.53%
| Category | Jun 2016 | Sep 2016 | Dec 2016 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Promoters | 74.94% | 74.94% | 29.65%▼45.3 | 77.16%▲47.5 | 77.16% | 77.16% | 77.15%▼0.0 |
| FIIs | 0% | 0% | 0% | 1.98%▲2.0 | 1.2%▼0.8 | 0.83%▼0.4 | 1.31%▲0.5 |
| DIIs | 0% | 0% | 0% | 10.57%▲10.6 | 14.37%▲3.8 | 15.42%▲1.1 | 13.02%▼2.4 |
| Public | 24.44% | 24.44% | 70.1%▲45.7 | 10.29%▼59.8 | 7.27%▼3.0 | 6.58%▼0.7 | 8.53%▲1.9 |
Financial Statements
| Metric | Jun 2016 | Sep 2016 | Dec 2016 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 24 | 29 | 24 | 67 | 95 | 68 | 82 | 84 | 89 | 81 |
| Expenses | 20 | 23 | 20 | 45 | 58 | 41 | 58 | 53 | 56 | 56 |
| Operating Profit | 4 | 6 | 5 | 22 | 36 | 27 | 25 | 31 | 33 | 25 |
| OPM % | 16% | 22% | 20% | 33% | 38% | 40% | 30% | 37% | 38% | 31% |
| Net Profit | -1 | 2 | 1 | 16 | 30 | 19 | 18 | 19 | 37 | 26 |
| EPS ₹ | -1.54 | 2.46 | 1.33 | 1.24 | 2.26 | 1.47 | 1.39 | 1.33 | 2.61 | 1.85 |
AI Insights
Revenue Trend
TTM revenue at ₹337Cr, up 8% YoY. OPM at 34%.
Debt Position
Borrowings at ₹119Cr. Debt-to-equity ratio: 0.13x. Healthy balance sheet.
Capex Cycle
CWIP at ₹65Cr (19% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 13.02% (+13.02pp change). FIIs: 1.31% (+1.31pp change). Promoters hold 77.15%.
Margin & Efficiency
ROCE improving from 1% (Mar 2014) to 18% (Mar 2025). Working capital days: -33.
Valuation
PE 38.4x with 18.2% ROCE. Price is 316% above book value of ₹65.4. Dividend yield: 0%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 2d - CRISIL issued March 31, 2026 IPO monitoring report; no deviation, proceeds largely utilized.
- Board Meeting Intimation for The Period Ended March 31, 2026 14 May - Board meeting on May 22, 2026 to approve audited FY2026 results; trading window reopens 48 hours later.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Apr - Filed Regulation 74(5) certificate for quarter ended March 31, 2026; no demat/remat requests received.
- Closure of Trading Window 26 Mar
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 6 Feb - Monitoring report: Q3 2025 utilization of Rs4,000m IPO proceeds; Rs2,100m repaid, Rs1,045m ASU underway
- Financial Year 2025 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse